346 related articles for article (PubMed ID: 30300334)
1. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
[TBL] [Abstract][Full Text] [Related]
4. CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.
Chen Y; Tian T; Mao MJ; Deng WY; Li H
BMC Cancer; 2018 May; 18(1):514. PubMed ID: 29720147
[TBL] [Abstract][Full Text] [Related]
5. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
Zhao LL
J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
7. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M
Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594
[TBL] [Abstract][Full Text] [Related]
8. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
[TBL] [Abstract][Full Text] [Related]
11. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
[TBL] [Abstract][Full Text] [Related]
14. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.
Liu TJ; Guo JL; Wang HK; Xu X
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1035-1043. PubMed ID: 29509252
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
Chen YH; Chen CH; Chien CY; Su YY; Luo SD; Li SH
BMC Cancer; 2021 Sep; 21(1):979. PubMed ID: 34465286
[TBL] [Abstract][Full Text] [Related]
17. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.
Liu PF; Hu YC; Kang BH; Tseng YK; Wu PC; Liang CC; Hou YY; Fu TY; Liou HH; Hsieh IC; Ger LP; Shu CW
PLoS One; 2017; 12(7):e0180620. PubMed ID: 28700659
[TBL] [Abstract][Full Text] [Related]
19. Appraising Oncogenic Long Noncoding RNAs as Novel Biomarkers for Oral Tongue Squamous Cell Carcinoma: a Meta-Analysis.
Cheng Y; Wang Y; Cui Z; Lin D; Zheng M; Cheng H
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532111
[TBL] [Abstract][Full Text] [Related]
20. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
